Non classé

Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma.

Nault JC, Campani C, Hirsch TZ, Neumann E, Arif W, Imbeaud S, Baretti M, Ziol M, Sidali S, Roger P, Allaire M, Bouattour M, Marra F, Fresneau B, Llarch N, Peron JM, Gerolami R, Khac EN, Nahon P, Ganne-Carrié N, Caldéraro J, Beaufrère A, Paradis V, Guettier C; CAPRIH FFCD cohort; Sutton A, Yarchoan M, …

Serum procalcitonin: A novel tumor biomarker for diagnosis and disease monitoring in fibrolamellar hepatocellular carcinoma. Read More »

Improving risk stratification and detection of early HCC using ultrasound-based deep learning models.

Dana J, Meyer A, Paisant A, Rode A, Sartoris R, Séror O, Cassinotto C, Milot L, Grégory J, Cœur J, Lebigot J, Schembri V, Villeret F, Takeda AN, Ronot M, Vilgrain V, Baumert TF, Gallix B, Padoy N, Nahon P. JHEP Rep. 2025 Jul 5;7(10):101510. Background & aims: Hepatocellular carcinoma (HCC) surveillance programs are suboptimal. …

Improving risk stratification and detection of early HCC using ultrasound-based deep learning models. Read More »

Associations between fruit and vegetable consumption and HCC occurrence in patients with cirrhosis.

Manneville F, Zouakia Z, Donneger S, Fezeu LK, Bellicha A, Nahon P, Touvier M, Ganne-Carrié N, Julia C. JHEP Rep. 2025 Feb 13;7(5):101355 Background & aims: Prospective studies are needed to increase knowledge of fruit and vegetable consumption effects on hepatocellular carcinoma (HCC) risk. This study aimed to investigate the association between fruit and vegetable …

Associations between fruit and vegetable consumption and HCC occurrence in patients with cirrhosis. Read More »

Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma.

Blaise L, Ziol M, Campani C, Ganne-Carrie N, Nahon P, Nkontchou G, Zucman-Rossi J, Del Pozo L, Barget N, Boros C, Desjonqueres E, Demory A, Grando V, Pescatori L, Seror O, Sutter O, Nault JC. JHEP Rep. 2025 Apr 22;7(9):101430. Background & aims: We aimed to assess the safety and diagnostic/prognostic value of tumor and …

Utility of tumor and non-tumor biopsies during percutaneous radiofrequency ablation for hepatocellular carcinoma. Read More »

The “A-B-C” Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab.

Campani C, Galvanin C, Shim JH, Bouattour M, Touchefeu Y, Delhoume V, Rosmorduc O, Pascale A, An J, Lee HC, Regnault H, Thabut D, Paradis V, Calderaro J, Ziol M, Beaufrère A, Sayadi A, Amaddeo G, Allaire M, Olivier-Hourmand I, Metivier C, Rondini E, Ronot M, Ntandja-Wandji L, Ozenne V, Sidali S, Marra F, Hollande …

The “A-B-C” Classification Reveals Outcome Trajectories in Patients With Hepatocellular Carcinoma Under Atezolizumab/Bevacizumab. Read More »

Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board.

Nault JC, Calderaro J, Ronot M.J Hepatol. 2024 Oct;81(4):756-762. doi: 10.1016/j.jhep.2024.05.041. Epub 2024 Jun 11.PMID: 38871125 Abstract Primary liver tumours, including benign liver tumours, hepatocellular carcinoma and cholangiocarcinoma, present a multifaceted challenge, necessitating a collaborative approach, as evidenced by the role of the multidisciplinary tumour board (MDTB). The approach to managing primary liver tumours involves specialised …

Integration of new technologies in the multidisciplinary approach to primary liver tumours: The next-generation tumour board. Read More »

Implementing advanced practice nursing in France: A country-wide survey 2 years after its introduction

Devictor J, Burnet E, Henriot T, Leclercq A, Ganne-Carrie N, Kilpatrick K, Jovic L Abstract Objectives: To examine the characteristics of the first Advanced Practice Nurses in France and to compare the French model to international standards. Background: Common barriers and facilitators to their integration in healthcare provision have been identified internationally. In France, the legislative framework was …

Implementing advanced practice nursing in France: A country-wide survey 2 years after its introduction Read More »

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response

Azzi J, Dorival C, Cagnot C, Fontaine H, Lusivika-Nzinga C, Leroy V, De Ledinghen V, Tran A, Zoulim F, Alric L, Gournay J, Bronowicki JP, Decaens T, Riachi G, Mikhail N, Soliman R, Shiha G, Pol S, Carrat F, Ganne-Carrié N; ANRS-AFEF Hepather Study group. Abstract Background & aims: Prediction of hepatocellular carcinoma (HCC) occurrence in patients …

Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response Read More »

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease

Nguyen N, Rode A, Trillaud H, Aubé C, Manichon AF, Hocquelet A, Paisant A, Dao T, Nahon P, Ganne-Carrié N, Blaise L, Cauchy F, Sutter O, Séror O, Nault JC Liver International, Décembre 2021 Background & aims: Long-term outcomes after percutaneous radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) in patients with non-alcoholic fatty liver disease (NAFLD) have …

Percutaneous radiofrequency ablation for hepatocellular carcinoma developed on non-alcoholic fatty liver disease Read More »

Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion

Blaise L, Pereira H, Vilgrain V, Sutter O, Gigante E, Walter A, Ganne-Carrié N, Nahon P, Bouattour M, Dioguardi Burgio M, Grando V, Nkontchou G, Seror O, Nault JC.Clin Res Hepatol Gastroenterol. 2021 Abstract Introduction: We aim to assess the outcomes of percutaneous ablation of locally advanced HCC in a tertiary center, which is usually not indicated. …

Percutaneous ablation for locally advanced hepatocellular carcinoma with tumor portal invasion Read More »